Skip to content
SentinelMarket desk
Switch to dark mode

한스바이오메드

042520KOSDAQView the 제약 sectorTheme Bio & healthcare

18,580KRWMarket close of 10/21 (Wed)

Down -2.21%-420KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)18,110KRWDown -2.53%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
19,150
High
19,520
Low
18,280
Day range
Day range low 18,280 high 19,520, open 19,150, close 18,580, previous close 19,000
Volume
13×10K shares
2.4B KRW 0.96× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 17,010 to 55,700 won, 4% up from the low

4% of the way up from the lowest close in 1 year (252 sessions) · -66.6% from the high

Usual range

Nothing unusual in the 5 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Daily moveusual range-2.21%-2.21%, 0.4× the usual (20-session average ±5.78%)
    That day -2.21% · usual ±5.78% · large-move threshold ±11.6%
  • Trading valueusual range1.0×2.4B KRW, 1.0× the 20-session average
    0.96× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional-100.00 million KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/23 (Fri) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.